Home » Topics » Science » New compound

New compound
RSS

AF-3581 demonstrates efficacy in animal models of mood disorders

Oct. 22, 2018

TAT therapy with [225Ac]RPS-074 effective in prostate cancer model

Oct. 22, 2018

IPR-166 enhances cognitive performance in a schizophrenia-like mouse model

Oct. 19, 2018

ONO-2910640 shows antidepressant-like effect in animal models of depression

Oct. 18, 2018

[18F]HTK-01174 shows promise for PET imaging of prostate cancer

Oct. 16, 2018

Astellas Cathespin S inhibitors prolong graft survival in a mouse cardiac transplant model

Oct. 16, 2018

Preclinical results presented for novel 6-amino-6-deoxy paramylon for the treatment of obesity

Oct. 11, 2018

Metabolic control seen in high-fat diet-fed mice by a novel hybrid peptide

Oct. 9, 2018

Discovery of the first nonpeptide OT-R agonist active in a mouse model of autism

Oct. 8, 2018

Hepato-preferential insulin analogue protects dogs from hypoglycemia

Oct. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...